Opportunity Information: Apply for PA 12 041
Apply for PA 12 041
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Mar 17, 2015 and posted on Nov 29, 2011.
- Applicants must submit their applications by Mar 17, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Public housing authorities/Indian housing authorities County governments City or township governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education State governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply.Non domestic (non U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International Research Collaboration on Drug Abuse and Addiction Research (R21) opportunity (Funding Opportunity Number PA 12 041) is a National Institutes of Health grant program designed to support early-stage, exploratory research projects that rely on meaningful collaboration outside the United States. The core idea is to fund studies in drug abuse and addiction science that can move faster or go further because the work can tap into special advantages located in other countries, such as unique scientific expertise, distinctive research resources, specific populations that are difficult to access in the U.S., or environmental and social conditions that create natural opportunities for discovery. Projects are expected to align with the mission of the National Institute on Drug Abuse (NIDA) and, when possible, connect to NIDA scientific priority areas, which can shift over time. For the referenced fiscal year (FY12), example priorities included research on the intersection of HIV/AIDS and drug abuse, as well as research focused on preventing, understanding initiation of, and improving treatment for nicotine and tobacco use, particularly among vulnerable groups such as children, adolescents, pregnant women, and people with co-morbid disorders.
This announcement uses the NIH R21 mechanism, which is typically intended for novel, high-impact ideas that may be at an earlier stage of development than larger, longer-term projects. The award ceiling listed for this opportunity is $200,000, and there is no cost sharing or matching requirement. The funding instrument type is a grant, and the primary activity area is education and health, tied to CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The program was posted on November 29, 2011, with dates in the record indicating an original closing date of January 7, 2015, a current closing date of March 17, 2015, and an archive date of April 17, 2015.
Eligibility is broad and includes many types of U.S. organizations and government entities, such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, other than institutions of higher education), small businesses, for-profit entities other than small businesses, and a range of state, county, city/township, special district, and independent school district governments. Tribal entities are also included, both federally recognized Native American tribal governments and other Native American tribal organizations. In addition, the announcement explicitly extends eligibility to several categories often highlighted in NIH programs, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. Importantly for an international collaboration program, non-U.S. entities (foreign institutions) are eligible to apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed.
The practical emphasis of the program is on research collaborations where the international setting is not incidental but is a scientific advantage that strengthens the project. Competitive applications would generally be expected to explain why conducting part or all of the work outside the United States is essential, what unique opportunities the foreign site(s) provide, how the collaboration will function in a way that adds scientific value, and how the resulting knowledge will advance drug abuse and addiction research in areas relevant to NIDA. The full announcement and detailed requirements were made available through the NIH grants page linked in the source material (http://grants.nih.gov/grants/guide/pa-files/PA-12-041.html). For technical issues accessing the announcement, the contact provided is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: International Research Collaboration on Drug Abuse and Addiction Research (R21) - PA-12-041
What is the name of this grant opportunity?
The opportunity is titled International Research Collaboration on Drug Abuse and Addiction Research (R21).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PA-12-041.
Which federal agency runs this program?
This is a National Institutes of Health (NIH) grant program and it is expected to align with the mission of the National Institute on Drug Abuse (NIDA).
What type of funding instrument is this?
The funding instrument type is a grant.
What grant mechanism does this announcement use?
This announcement uses the NIH R21 mechanism, which is typically intended for early-stage, exploratory projects focused on novel, potentially high-impact ideas.
What is the main goal of this program?
The program is designed to support early-stage, exploratory drug abuse and addiction research that relies on meaningful collaboration outside the United States, where the international setting provides scientific advantages that help the research move faster or go further.
What kinds of international advantages is the program looking for?
Applications are expected to show that the international setting provides a clear scientific advantage, such as:
- Unique scientific expertise available in another country
- Distinctive research resources located outside the U.S.
- Access to specific populations that are difficult to access in the United States
- Environmental or social conditions that create natural opportunities for discovery
Is the international collaboration optional, or is it central to the program?
The practical emphasis is on collaborations where the international setting is not incidental. Competitive applications would generally explain why work outside the U.S. is essential and how the foreign site(s) strengthen the project scientifically.
What research areas does this program support?
The opportunity supports research in drug abuse and addiction science that aligns with NIDA's mission. When possible, projects should connect to NIDA scientific priority areas, which can change over time.
What were example NIDA priorities referenced for FY12?
For the referenced fiscal year (FY12), example priorities included:
- Research on the intersection of HIV/AIDS and drug abuse
- Research on preventing, understanding initiation of, and improving treatment for nicotine and tobacco use
- A particular emphasis on vulnerable groups such as children, adolescents, pregnant women, and people with co-morbid disorders
What is the maximum award amount listed for this opportunity?
The award ceiling listed for this opportunity is $200,000.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
What is the CFDA number for this program?
The CFDA number provided is 93.279, labeled Drug Abuse and Addiction Research Programs.
What is the primary activity area for this opportunity?
The primary activity area is listed as education and health.
When was this opportunity posted?
The program was posted on November 29, 2011.
What are the closing and archive dates shown in the record?
The record indicates:
- Original closing date: January 7, 2015
- Current closing date: March 17, 2015
- Archive date: April 17, 2015
Who is eligible to apply from the United States?
Eligibility is broad and includes many U.S. organization types and government entities, including:
- Public and private institutions of higher education
- Nonprofits (with or without 501(c)(3) status, other than institutions of higher education)
- Small businesses
- For-profit entities other than small businesses
- State, county, city/township, special district, and independent school district governments
- Federally recognized Native American tribal governments and other Native American tribal organizations
- Eligible federal agencies
- U.S. territories or possessions
Are specific institution types explicitly called out as eligible?
Yes. The announcement explicitly highlights eligibility for categories often emphasized in NIH programs, including:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-serving institutions
- Alaska Native and Native Hawaiian Serving Institutions
- Tribally Controlled Colleges and Universities (TCCUs)
- Faith-based and community-based organizations
- Regional organizations
Can foreign (non-U.S.) organizations apply?
Yes. The announcement states that non-U.S. entities (foreign institutions) are eligible to apply.
Are non-U.S. components of U.S. organizations eligible?
Yes. The announcement states that non-U.S. components of U.S. organizations are eligible.
Are foreign components allowed under NIH policy?
Yes. The announcement specifies that foreign components (as defined by NIH policy) are allowed.
What makes an application competitive for this opportunity?
Based on the description provided, competitive applications would generally be expected to:
- Explain why conducting part or all of the work outside the United States is essential
- Describe the unique opportunities provided by the foreign site(s)
- Explain how the collaboration will function in a way that adds scientific value
- Show how the resulting knowledge will advance drug abuse and addiction research relevant to NIDA
Where can applicants find the full announcement and requirements?
The full announcement is available on the NIH grants page at: http://grants.nih.gov/grants/guide/pa-files/PA-12-041.html
Who should be contacted for technical issues accessing the announcement?
For technical issues accessing the announcement, the contact provided is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R03)
Previous opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 12 041
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 12 041) also looked into and applied for these:
| Funding Opportunity |
|---|
| International Research Collaboration on Drug Abuse and Addiction Research (R03) Apply for PA 12 042 Funding Number: PA 12 042 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Limited Competition Competitive Revision for Technology Development within Biomedical Technology Research Centers (P41) Apply for PAR 12 046 Funding Number: PAR 12 046 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Cancer Education Grants Program (R25) Apply for PAR 12 049 Funding Number: PAR 12 049 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Palliative Care and End of Life in People Living with HIV/AIDS(R01) Apply for RFA NR 12 004 Funding Number: RFA NR 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Palliative Care and End of Life in People Living with HIV/AIDS (R21) Apply for RFA NR 12 005 Funding Number: RFA NR 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 12 055 Funding Number: PAR 12 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition The Medical Education Partnership Initiative Linked Awards (MEPI) (R25) Apply for RFA TW 11 004 Funding Number: RFA TW 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| The Chernobyl Tissue Bank Coordinating Center (Limited Competition U24) Apply for RFA CA 12 501 Funding Number: RFA CA 12 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 12 050 Funding Number: PAR 12 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 12 051 Funding Number: PAR 12 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 12 052 Funding Number: PAR 12 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 12 061 Funding Number: PA 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 12 062 Funding Number: PAR 12 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Stage Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 12 002 Funding Number: RFA CA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 12 003 Funding Number: RFA CA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 12 004 Funding Number: RFA CA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 12 005 Funding Number: RFA CA 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| NCI Established Investigator Award in Cancer Prevention and Control (K05) Apply for PAR 12 065 Funding Number: PAR 12 065 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Imaging Science Track Award for Research Transition (I/START) R03 Apply for PAR 12 066 Funding Number: PAR 12 066 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Human Health and Heredity in Africa (H3Africa) Research Grants (U01) Apply for RFA RM 12 004 Funding Number: RFA RM 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 12 041", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.